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Epidemiological data suggest that those who consume a diet rich in quercetin-containing foods may have a reduced risk of CVD. Furthermore, in
vitro and ex vivo studies have observed the inhibition of collagen-induced platelet activation by quercetin. The aim of the present study was to
investigate the possible inhibitory effects of quercetin ingestion from a dietary source on collagen-stimulated platelet aggregation and signalling.
A double-blind randomised cross-over pilot study was undertaken. Subjects ingested a soup containing either a high or a low amount of quercetin.
Plasma quercetin concentrations and platelet aggregation and signalling were assessed after soup ingestion. The high-quercetin soup contained
69mg total quercetin compared with the low-quercetin soup containing 5mg total quercetin. Plasma quercetin concentrations were significantly
higher after high-quercetin soup ingestion than after low-quercetin soup ingestion and peaked at 2·59 (SEM 0·42) mmol/l. Collagen-stimulated
(0·5mg/ml) platelet aggregation was inhibited after ingestion of the high-quercetin soup in a time-dependent manner. Collagen-stimulated tyrosine
phosphorylation of a key component of the collagen-signalling pathway via glycoprotein VI, Syk, was significantly inhibited by ingestion of the
high-quercetin soup. The inhibition of Syk tyrosine phosphorylation was correlated with the area under the curve for the high-quercetin plasma
profile. In conclusion, the ingestion of quercetin from a dietary source of onion soup could inhibit some aspects of collagen-stimulated platelet
aggregation and signalling ex vivo. This further substantiates the epidemiological data suggesting that those who preferentially consume high
amounts of quercetin-containing foods have a reduced risk of thrombosis and potential CVD risk.
Quercetin: Platelets: glycoprotein VI: Phytochemicals: CVD: Signalling
The relationship between a diet high in fruits and vegetables
and a decreased risk of CVD is well established, although
an explanation for this is far from clear. The relationship
between diet and platelet function is complex and is not under-
stood. A number of studies have focused on the effects of diet-
ary antioxidants on platelet function, among which are the
flavonols. The flavonols are a subgroup of polyphenolic com-
pounds present in fruits and vegetables and are thought to play
a role in the reduction of incidence of chronic diseases (Hertog
et al.1995, 1997); they have also been reported to inhibit pla-
telet aggregation (Beretz et al. 1982; Landolfi et al. 1984;
Hubbard et al. 2003, 2004). Quercetin (and its conjugate
forms) is a key flavonol in the human diet and is found in
high levels in onions, apples, tea and wine (Hertog et al.
1992). One of the quercetin conjugates, quercetin 40-glucoside,
is a principal form of quercetin in the diet, particularly high
levels being present in onions. This form has been found to
be preferentially absorbed in the gut in human studies invol-
ving single meals or supplementation with purified compound
(Aziz et al. 1998; Hollman et al. 1999; McAnlis et al. 1999;
Hubbard et al. 2004). Quercetin has been shown to be a
very potent bioactive molecule by possessing anti-inflamma-
tory, anti-allergenic, antiviral, anticancer, antioxidant and
anti-thrombotic actions, among others (reviewed by Formica
& Regelson, 1995).
We have recently reported that quercetin and quercetin-40-
glucoside potently inhibit collagen-stimulated platelet
aggregation and collagen receptor (glycoprotein VI (GPVI))-
mediated signalling in vitro and ex vivo (Hubbard et al. 2003,
2004). Quercetin has been shown to preferentially inhibit col-
lagen-stimulated platelet aggregation and the tyrosine phos-
phorylation and/or activity of a number of critical components
of the GPVI signalling pathway in vitro. These include the
non-receptor tyrosine kinase Syk, phospholipase Cg2 (PLCg2)
and phosphoinositide 3-kinase. The inhibition concentration50
values for the inhibition of platelet aggregation by quercetin
were below 3mmol/l when platelets were stimulated with con-
centrations of collagen between 0·5 and 1·0mg/ml
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(Hubbard et al. 2003). The in vivo effects of quercetin on platelet
function were demonstrated after subjects ingested purified
quercetin 40-glucoside. Plasma quercetin levels peaked at
9·7mmol/l, and collagen-stimulated platelet aggregation and
signalling via GPVI were significantly inhibited after the inges-
tion of both 150 and 300mg doses of quercetin
40-glucoside (Hubbard et al. 2004). The effects of supplemen-
tation with quercetin 40-glucoside on platelet signalling and
function mirrored those observed in the in vitro study.
The anti-thrombotic effects of quercetin derived from a
dietary source have not been investigated. In the present
study, we have investigated the possible inhibitory effects of
quercetin ingestion from a dietary source on collagen-stimu-
lated platelet aggregation and signalling.
Subjects and methods
Human supplementation study design
Consent from the University of Reading Ethics Committee
was obtained before the start of the study. Two types of
onion soup (see later for details), one high in quercetin gluco-
sides and the other with low quercetin glucoside levels, were
ingested to investigate the effects of quercetin on collagen-
stimulated platelet function and signalling. The study was a
two-treatment, randomised, double-blind, cross-over study in
which six subjects (four men and two women; age 34 (SD 7)
years; weight 68·5 (SD 3·6) kg; BMI 23·1 (SD 2·0) kg/m2)
abstained from ingesting aspirin and complied with a low-
quercetin diet for 14 d prior to the study to ensure quercetin
washout (foods low in quercetin were defined according to
Hertog et al. (1992)). Following a 12 h overnight fast, the sub-
jects then took part in a 1 d study. They were cannulated, and a
baseline blood sample was taken. The subjects then ingested
either the high- or the low-quercetin soup (600 ml), the
order being randomised. Blood samples were then taken at
30, 60, 90, 120, 150, 180, 210, 240, 300, 360, 390 and
420min after soup ingestion and at 24 and 32 h for the deter-
mination of plasma quercetin level. Blood samples taken at 0,
1 and 3 h were also used to examine the effect of soup inges-
tion on platelet function and signalling. The study day was fol-
lowed by a 1-month washout period, after which the subject
ingested the remaining treatment.
Soup preparation
Batches of near-isogenic high- and low-quercetin onions (Femia
et al. 2003) were used to prepare high- and low-quercetin onion
soups. The soups were prepared in the samemanner on the same
day in one batch and then frozen at 2208C. For each person,
chopped onions (500 g, equivalent to approx. three medium-
sized onions) were added to 500ml boiling water and blanched
for 2min. The onions were then drained (retaining the blanching
liquid) and added to a large saucepan containing 25 g butter and
7·5ml refined olive oil before being fried for 10min until they
started to brown. Meanwhile, 1·5 rounded teaspoons of Swiss
Vegetable Bouillon Powder (Marigold Health Foods, London,
UK) was added to the blanching liquid to make a stock, and
this was then added to the fried onions. The saucepan was then
covered and left to simmer for 30min. The soup was left to
cool and then liquidised; 600ml portions were then frozen at
2208C until use. The two soups were analysed for flavonoid
content by preparing both non-hydrolysed and hydrolysed
extracts (with 0·5% t-butylated hydroxyquinone as an antioxi-
dant) followed by HPLC, as previously described (Bovy et al.
2002). Quercetin was used as a standard to quantify both glyco-
sides and the aglycone (Table 1). On the day of use, the portions
of soup were defrosted and then reheated in a microwave. The
subjects then consumed the soup within 15min and were not
allowed to ingest any other food or drink, apart from water,
during the following 4 h.
Materials
b-Glucuronidase/sulphatase (crude extract from Helix poma-
tia) and protein A-sepharose 4BL were purchased from
Sigma (Poole, Dorset, UK). Horm-Chemie collagen (col-
lagen-fibres from equine tendons) was purchased from
Nycomed (Munich, Germany). Anti-phosphotyrosine mono-
clonal antibody (4G10) came from Upstate Biotechnology
(TCS Biologicals, Botolph Claydon, Buckinghamshire,
UK). Anti-Syk (N-19), anti-Syk (LR) and anti-PLCg2 poly-
clonal antibodies were purchased from Santa Cruz Biotech-
nology (Autogen Bioclear UK Ltd, Calne, Wiltshire, UK).
Horseradish peroxidase-conjugated secondary antibodies
(anti-rabbit IgG, anti-mouse IgG), the enhanced chemilumi-
nescence immuno-detection system and Hyperfilm were pur-
chased from Amersham Biosciences (Little Chalfont,
Buckinghamshire, UK). Quercetin, kaempferol, isorhamnetin,
tamarixetin, rhamnetin and all chemicals used for preparing
the HPLC eluent were purchased from Roth (Karlsruhe,
Germany).
Preparation and stimulation of platelets
Platelets were prepared from the blood samples collected from
subjects at the 0, 1 and 3 h time points on the day of the exper-
iment by differential centrifugation as previously described
(Gibbins et al. 1997) and were suspended in modified
Tyrodes-Hepes buffer (134mmol/l NaCl, 0·34mmol/l
Na2HPO4, 2·9mmol/l KCL, 12mmol/l NaHCO3, 20mmol/l
Hepes, 5mmol/l glucose, 1mmol/l MgCl2, pH 7·3) at a density
of 2 £ 108 cells/ml for aggregation experiments. Stimulation
of platelets (450ml) with collagen (50ml; 0·5, 1, 2 and 3mg/
ml final concentration) was performed at 378C in an optical
platelet aggregometer (Chrono-log Corporation, Havertown,
PA, USA) with continuous stirring (1200 rpm).
For immunoprecipitation and immunoblotting experiments,
platelets were suspended at 8 £ 108 cells/ml in Tyrodes-Hepes
buffer containing 1mmol/l EGTA to prevent aggregation.
Table 1. Levels of quercetin in onion soups as ingested (mg/l)
(Values were means of two replicate analyses)
Onion type
Quercetin
aglycone
Quercetin
40-glucoside
Quercetin
3, 40-glucoside Total
Low-quercetin
onions
0·1 3·8 4·3 8·2
High-quercetin
onions
1·1 53·2 60·5 114·8
For details of subjects and procedures, see this page.
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Based on previous platelet signalling studies (Hubbard et al.
2003, 2004), the concentration of collagen was increased to
25mg/ml to enable the detection of tyrosine phosphorylation
events. This was necessary because, for successful immuno-
precipitation of proteins from platelets, they were stimulated
in the presence of EGTA to prevent fibrinogen-dependent
aggregation. Although this ensured equivalent levels of pro-
tein isolation from activated and non-activated platelets, it
resulted in lower levels of positive-feedback signalling
through the fibrinogen receptor, integrin aIIbb3, and therefore
in comparison to stimulation under aggregating conditions,
higher agonist concentrations were required in order to
measure protein tyrosine phosphorylation (Cicmil et al. 2002).
Platelet stimulationwas terminated by the addition of an equal
volume of ice-cold NP40 lysis buffer, (2% v/v Nonidet P40,
20mmol/l Tris, 300mmol/l NaCl, 10mmol/l EDTA, 1mmol/l
phenylmethylsulfonyl fluoride, 2mmol/l Na3VO4, 10mg/ml leu-
peptin, 10mg/ml aprotonin, 1mg/ml pepstatin A, pH 7·3). Deter-
gent-insoluble debris was removed by centrifugation (14 000g
for 10min), and samples were frozen at 288C until analysis.
For immunoprecipitation studies, whole cell lysates were pre-
cleared bymixingwith protein A-sepharose (60ml 50%w/v sus-
pension in Tris-buffered saline-Tween (20mnol/l Tris,
137mmol/l NaCl, 0·1% v/v Tween 20, pH 7·6)) for 1 h at 48C.
Protein A-sepharose was removed by centrifugation before
adding the relevant antibody (anti-Syk (LR) or anti-PLCg2
(1mg/ml)). Following rotation for 1 h at 48C, 60ml protein
A-sepharose suspension was added to each sample and rotated
for a further 1 h at 48C, before washing the sepharose pellet and
adding the reducing Laemmli buffer. Immunoprecipitated pro-
teins were separated by SDS-PAGE under reducing conditions
using 10% gels and transferred to polyvinylidene difluoride
membranes by semi-dry western blotting
Immunoblotting
Membranes were blocked by incubation in 10% (w/v) bovine
serum albumin dissolved in Tris-buffered saline-Tween. Pri-
mary and secondary antibodies were diluted in Tris-buffered
saline-Tween containing 2% (w/v) bovine serum albumin,
and incubated with membranes for 1 h at room temperature
with rotation. Blots were washed for 2 h in Tris-buffered
saline-Tween following each incubation with antibodies and
were developed using an enhanced chemiluminescence detec-
tion system. Primary antibodies were used at a concentration
of 1mg/ml anti-phosphotyrosine antibody (4G10), anti-Syk
(N-19), anti-PLCg2) and horseradish peroxidase-conjugated
secondary antibody (anti-mouse-horseradish peroxidase, anti-
rabbit-horseradish peroxidase) was diluted 1:10 000.
Densitometry analysis was carried out using a Bio-Rad
GS710 densitometer with Quantity One analysis software
(Bio-Rad, Hemel Hempstead, Hertfordshire, UK).
Plasma concentrations of quercetin, isorhamnetin and
tamarixetin
Plasma concentrations of flavonoids were measured as pre-
viously described (Ader et al. 2000). Briefly, blood was
taken into 10ml EDTA vacutainer system blood tubes.
Plasma was prepared by centrifugation for 10min at 2000 g
and stored at 2808C until analysis. An 800ml aliquot of the
plasma sample was acidified with 100ml acetic acid (0·583
M), spiked with 20ml rhamnetin (internal standard 50mg/ml
in methanol) and subsequently treated with a mixture of 104
units b-glucuronidase/2·5 £ 102 units sulphatase (crude extract
from Helix pomatia). After an incubation of 1 h at 378C, the
flavonol aglyca quercetin, kaempferol, isorhamnetin and tamar-
ixetin were simultaneously extracted with 5·5ml acetone. The
mixture was centrifuged at 3700 g for 45min and the super-
natant evaporated under vacuum at 458C to dryness. The resi-
due was resolved in 200ml methanol, 77·5ml nanopure H2O
and 22·5mL HCl (10mol/l).
For HPLC analysis, 30ml were injected onto a C-18 Kromasil
100 column (dimensions 250 £ 4mm, particle size 5mm)
guarded by a C-18 Inertsil ODS-2 precolumn (Jasco,
Groß-Umstadt, Germany). The eluent (1ml/min) was composed
of 0·025mol/l NaH2PO4, pH 2·4, acetonitrile and methanol
(68:27:5 v/v/v). The column effluent was mixed with 0·4ml/
min 1·0mol/l Al(NO3)3 in methanol containing 7·5% (v/v)
acetic acid in a post-column reactor (Jasco). The column and
the reactor were placed in a column oven at 308C. The fluor-
escence of the ensuing flavonol-metal complex was measured
at 485 nm using a fluorescence detector with an excitation wave-
length of 422 nm. The limit of detection was 3 ng/ml.
Statistics
All statistical analyses were performed using SPSS for win-
dows version 10.0 (SPSS, Chicago, IL, USA). Data were
checked for normality and log (base 10) transformed if necess-
ary. Univariate ANOVA, two-factor within-subjects ANOVA
with Tukey as a post hoc test, Pearson’s correlations and
paired-sample Student’s t tests were used; P values #0·05
were taken as significant. In all graphs, data are presented as
mean values (six subjects) with their standard errors of the
mean unless stated otherwise.
Results
Flavonoid composition of the high- and low-quercetin soups
The flavonoid concentrations of the soups derived from high-
and low-quercetin onions were determined by HPLC analysis
(Table 1). From the non-hydrolysed extracts, it appeared that,
after cooking, 99% of the total quercetin concentration was
still present as glycosides, in a ratio of quercetin 40-glucoside
to quercetin 3,40-glucoside of 0·88:1, for both the low- and
high-quercetin soups. This ratio is in agreement with the pre-
vious findings of de Pascual-Teresa et al. (2004). Thus, in the
present study, each subject consumed 600ml soup containing
a total amount of 68·8 or 4·9mg quercetin, for the high- and
low-quercetin soups, respectively.
Plasma flavonol concentrations following ingestion of onion
soup
Following ingestion of the high-quercetin and low-quercetin
soups, the concentrations of quercetin and two of its metab-
olites with an intact flavonol structure, isorhamnetin and
tamarixetin, were quantified in blood plasma. At 90min
after ingesting the high-quercetin soup, mean plasma querce-
tin concentrations peaked at 2·59 (SEM 0·42) mmol/l
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(P¼0·0001; two-factor within-subjects ANOVA; Fig. 1A),
and then decreased steadily, returning to basal levels after
32 h. The mean area under the curve for the high-quercetin
soup plasma profile was 911·61 (SEM 85·17) mmol/l per min,
significantly higher than the mean area under the curve for
the low-quercetin soup plasma profile (P¼0·001; paired Stu-
dent’s t test). Plasma quercetin levels after low-quercetin
soup ingestion were negligible.
Peak plasma isorhamnetin concentrations occurred 2 h after
ingestion of the quercetin soups at 0·119 (SEM 0·02) mmol/l
and 0·0133 (SEM 0·04) mmol/l (P¼0·0001; two-factor within-
subjects ANOVA) for the high- and low-quercetin soups
respectively (Fig. 1B). Plasma isorhamnetin levels thereafter
declined slowly, returning to basal levels by 32 h. Peak plasma
concentrations of tamarixetin occurred 2·5 h after ingestion of
the soups at 0·172 (SEM 0·035) mmol/l and 0·0049 (SEM 0·001)
mmol/l (P¼0·0001; two-factor within subjects ANOVA) for
the high- and low-quercetin soups respectively (Fig. 1C).
Plasma levels declined thereafter with very similar kinetics to
those of isorhamnetin.
The sum of the plasma concentrations of the three flavo-
noids is shown in Fig. 1D. Total flavonoid concentrations
peaked at 90min and were 2·88 (SEM 0·47) mmol/l and
0·122 (SEM 0·122) mmol/l (P¼0·0001; two-factor within-sub-
jects ANOVA) for the high- and low-quercetin soups, respect-
ively. At all time points from 30 to 420min after soup
ingestion, significantly higher concentrations of total flavo-
nols, quercetin and metabolites (tamarixetin, isorhamnetin)
were observed after the high-quercetin soup than after the
low-quercetin soup and when compared with baseline
concentrations (P¼0·0001; two-factor within subjects
ANOVA with Tukey as a post hoc test).
High-quercetin soup ingestion inhibits collagen-stimulated
platelet aggregation
Ingestion of the high-quercetin soup inhibited platelet aggrega-
tion (ex vivo) at 1 and 3 h after ingestion (Fig. 2) compared with
baseline and when corrected for the effect of low-quercetin soup
ingestion on platelet aggregation. The inhibitory effect was
greater 3 h after ingestion of the high-quercetin soup, when pla-
telets were stimulated with 0·5, 1 and 2mg/ml collagen. Indeed,
the inhibition of platelet aggregation was dependent on the con-
centration of collagen used to stimulate aggregation, with higher
concentrations of collagen overcoming the inhibitory effect of
the treatment. Platelet aggregation was adjusted for the level
of response measured following ingestion of the low-quercetin
soup. Although the trends observed were quite dramatic, they
did not achieve statistical significance in this assay, possibly
owing to the natural variability of platelet responses to collagen
in different individuals and the small subject number possible
in this pilot study. There was little effect on platelet aggregation
following ingestion of the low-quercetin soup with a mean
increase of 9·6 (SEM 5·4) %.
High-quercetin soup ingestion inhibits collagen-stimulated
signalling in platelets
Owing to the potent inhibitory activity of quercetin on platelet
aggregation and signalling in vitro (Hubbard et al. 2003) and
the inhibitory effect of high-quercetin soup ingestion on platelet
aggregation ex vivo (Fig. 2), the effect of high-quercetin soup
ingestion on collagen-stimulated signalling was investigated.
In our previous study (Hubbard et al. 2004), inhibition of
the tyrosine phosphorylation of critical proteins in the GPVI
signalling pathway, namely Syk and PLCg2, was observed
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Fig. 1. The effect of ingestion of high-quercetin (B) or low-quercetin (†) soup on plasma concentrations of (A) quercetin, (B) isorhamnetin, (C) tamarixetin and (D)
total of the three flavonols. Subjects ingested 600 ml high- or low-quercetin soup. Blood samples were taken into K3 EDTA tubes and centrifuged, and the plasma
was frozen at 2808C. Plasma flavonol concentrations were derived by HPLC analysis with fluorescence detection. The concentration of flavonols in plasma is
shown for a 32 h period (n 6; mean values with their standard errors *P¼0·0001). At all time points from 30 to 420 min, significantly higher concentrations of total
flavonols, quercetin and metabolites (tamarixetin and isorhamnetin) were observed after ingestion of the high-quercetin soup than after ingestion of the low-quer-
cetin soup and when compared with baseline concentrations (P¼0·0001; two-factor within-subjects ANOVA with Tukey as a post hoc test).
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upon ingestion of a purified quercetin-containing drink. In the
present study, differential effects of the quercetin soup ingestion
were observed. When the low-quercetin soup was ingested, col-
lagen-stimulated Syk tyrosine phosphorylation increased com-
pared with baseline at 1 and 3 h, whereas upon ingestion of the
high-quercetin soup, collagen-stimulated Syk tyrosine
phosphorylation was inhibited at 1 and 3 h compared with base-
line and reached statistical significance at 1 h (P¼0·003;
ANOVA with Tukey as a post hoc test) (Fig. 3). The inhibition
of Syk tyrosine phosphorylation upon high-quercetin soup
ingestion was time dependent, a greater effect being observed
3 h after soup ingestion. Syk tyrosine phosphorylationwas nega-
tively correlated with the area under the curve for the high-quer-
cetin plasma profile at both 1 and 3 h (P¼0·022, r20·650, and
P¼0·007, r20·734 for the 1 h and 3 h time points respectively,
andP¼0·0001, r20·699 for the 1 and 3 h values together (total;
Pearson’s correlation).
Similarly collagen-stimulated tyrosine phosphorylation of
PLCg2 also increased upon low-quercetin soup ingestion, com-
pared with baseline at 1 and 3 h, whereas upon ingestion of the
high-quercetin soup, collagen-stimulated PLCg2 tyrosine phos-
phorylation was inhibited at 1 and 3 h compared with baseline.
Both these effects were less potent with time (Fig. 4).
Discussion
The inhibitory effect of dietary flavonoids on platelet function
has been recognised for some time, but controversy surrounds
the proposition that this may underlie some of the protective
effects of a diet rich in flavonoids. Indeed, it has been
suggested that quercetin is poorly absorbed through the gut
and therefore does not reach the plasma at levels that affect
platelet function. We have, however, recently reported the
identity of specific targets of collagen-mediated signalling
pathways that lead to platelet activation and are inhibited by
quercetin in vitro; these include src-family kinases, the
tyrosine kinase Syk and phosphoinositide 3-kinase (Hubbard
et al. 2003). These inhibitory effects were mirrored ex vivo
upon ingestion of quercetin 40-glucoside in the form of a sup-
plement drink (Hubbard et al. 2004).
Recent reports demonstrate that quercetin bioavailability is
highly dependent on the form of quercetin that is ingested. Quer-
cetin 40-glucoside has been reported to be preferentially
absorbed into the body from the gut in comparison to other
forms of quercetin, such as quercetin 3-O-b-rutinoside
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Fig. 3. The effect of onion soup ingestion on tyrosine phosphorylation of Syk
in platelets. Subjects ingested 600 ml high- or low-quercetin soup. Washed
platelets were prepared 0, 1 and 3 h after ingestion of the soup. Platelets
were then stimulated under non-aggregating conditions with collagen
(25mg/ml) for 90 s. Platelets were then lysed, and Syk was immunoprecipi-
tated and separated by SDS-PAGE, followed by immunoblotting for phospho-
tyrosine residues, and then reprobed for equal loading of Syk. (A)
Representative phosphotyrosine blot. (B) Densitometry analysis of Syk tyro-
sine phosphorylation of all subjects compared with baseline (0 h) values (n 6;
mean values with their standard errors; **P¼0·003 high-quercetin compared
with low-quercetin soup).
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Fig. 4. The effect of onion soup ingestion on tyrosine phosphorylation of
phospholipase Cg2 (PLCg2) in platelets. Subjects ingested 600 ml high- or
low-quercetin soup. Washed platelets were prepared from whole blood 0
(before soup ingestion), 1 and 3 h after ingestion of the soup. Platelets were
then stimulated under non-aggregating conditions with collagen (25mg/ml)
for 90 s. Platelets were then lysed, and PLCg2 was immunoprecipitated and
separated by SDS-PAGE, followed by immunoblotting for phosphotyrosine
residues, and then reprobed for equal loading of PLCg2. (A) Representative
phosphotyrosine blot. (B) Densitometry analysis of PLCg2 tyrosine phos-
phorylation of all subjects compared with baseline (0 h) values (n 6; standard
error of the mean).
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Fig. 2. High-quercetin soup ingestion inhibits collagen-induced platelet aggre-
gation 1 and 3 h after consumption compared with baseline. Washed plate-
lets were prepared at 0 (before soup ingestion), 1 (B) and 3 (A) h after
ingestion of the soup. The platelets were stimulated with concentrations of
collagen, and the aggregation response was monitored for 90 s. Percentage
change in platelet aggregation compared with baseline and corrected for low-
quercetin soup is shown for four concentrations of collagen (n 6; standard
error of the mean).
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(Hollman et al. 1999; Hubbard et al. 2004), with peak plasma
quercetin concentrations reported in the range 5–10mM. In
experiments previously described (Hubbard et al. 2003, 2004),
quercetin inhibited collagen-stimulated cell signalling and pla-
telet aggregation in vitro and ex vivo at similar concentrations.
The aims of the present study were to explore the bioavail-
ability of quercetin from a dietary source such as onion soup,
and to determine whether the levels adsorbed into blood
plasma reached levels that were able to inhibit collagen-
mediated signalling in platelets and thereby reduce platelet
aggregation responses. Published estimates of the daily dietary
intake of flavonoids vary considerably, with reports of 26mg/d
for flavonols (a subgroup of flavonoids; Hertog et al. 1995) to
1·26 g/d total phenolics in a group of vegetarian women
(Gosnay et al. 2002). The dose of quercetin supplied by the
high-quercetin soup (69mg total quercetin) was chosen as a
high dose of dietary quercetin compared with population esti-
mates (Hertog et al. 1995), but one that could be achieved by
dietary means. The dose of quercetin supplied by the low-
quercetin soup (4mg total quercetin) was 17-fold lower and
represented a low dose compared with population estimates
(Hertog et al. 1995; Gosnay et al. 2002).
Following ingestionof the high- and low-quercetin soups, anal-
ysis of the quercetin concentration in plasma revealed that querce-
tin was absorbed from the gut into the bloodstream after ingestion
of both soups, but peak quercetin levelswere over 150-fold higher
after ingestion of the high-quercetin soup. The concentration of
quercetin measured in plasma samples encompassed all forms
of quercetin (total quercetin). The plasma samples were enzymi-
cally treated to yield free quercetin, allowing no differentiation
between conjugates such as glucuronides and sulphates, which
are difficult to identify in plasma, owing to the lack of standards.
The peak plasma concentrations of the methylated metabolites of
quercetin, namely isorhamnetin and tamarixetin, were approxi-
mately 20- and 15-fold lower, respectively, than those of querce-
tin after high-quercetin soup ingestion. Isorhamnetin and
tamarixetin were also measured in plasma following enzymic
treatment; thus, the agylcone form of these compounds was not
detected in plasma. These compounds are therefore thought to
be present in blood plasma in conjugate forms such as glucuro-
nides or sulphates. The parallel absorption and elimination pro-
files of all three compounds detected suggests that the
methylated metabolites isorhamnetin and tamarixetin were
derived from the intestinal and/or hepatic metabolism of querce-
tin, as suggested by Manach et al. (1996) and Ader et al. (2000).
The conjugates of quercetin couldnot be detected in plasma, so
the identity of the dominant or bioactive conjugate form of quer-
cetin was not addressed in this study. The onion soups have been
shown to contain the quercetin aglycone, quercetin 40-O-b-D-
glucoside and quercetin 3, 40-glucoside (de Pascual-Teresa et al.
2004), but which of these quercetin derivatives or of their metab-
olites is the active form is an important issue to resolve.
If the peak plasmaquercetin concentrations from the quercetin-
supplementation study (Hubbard et al. 2004) are compared with
the results observed in the present study, a dose-dependent
effect can be seen. In the present study, 69mg total quercetin
(of which 32mg was quercetin 40-glucoside) in the form of
onion soup was fed to subjects, producing a plasma peak of
2·59mM. In the previous supplementation study, 150 and
300mg purified quercetin 40-glucosidewere ingested by subjects,
producing plasma peaks of 4·66 and 9·72mmol/l, respectively.
Collagen-stimulated platelet aggregation was inhibited by
ingestion of the high-quercetin soup. The inhibitory effect was
dependent on the concentration of collagen used to stimulate
platelet aggregation, consistent with previous in vitro and ex
vivo data (Hubbard et al. 2003, 2004). The inhibition of platelet
aggregation by collagen after ingestion of the high-quercetin
soup was also time-dependent, more potent effects being seen
3 h after ingestion of the soup compared with 1 h.
Very few studies have investigated the acute effects of dietary
supplementation of flavonoids on platelet function. Studies
investigating the effects of black tea ingestion on ADP and col-
lagen-induced platelet aggregation have reported little effect
(Duffy et al. 2001; Hodgson et al. 2002). The chronic ingestion
of polyphenol-rich foods has been observed to inhibit platelet
aggregation by Keevil et al. (2000), who supplemented ten sub-
jects with purple grape juice for 7 d; this inhibited whole-blood
platelet aggregation induced with collagen (1mg/ml) by 77%.
Other similar studies have, however, reported no significant
inhibitory effect of the ingestion of polyphenol-rich foods on
platelet aggregation (Conquer et al. 1998; Janssen et al. 1998).
A number of these studies used high concentrations of agonist
to stimulate platelet aggregation. Janssen et al. (1998) used col-
lagen as an agonist at 2·0mg/ml, and Conquer et al. (1998) used
collagen at 10mg/ml. In the present study, the inhibition of pla-
telet aggregation by ingestion of the high-quercetin soup was
more potent with the lower concentrations of collagen (0·5 and
1·0mg/ml). It is likely that discrepancies between these studies
are attributable to a combination of factors including potencies
of agonists, sources of polyphenols, other dietary factors and
donor variability in platelet responses.
In the present study, tyrosine phosphorylation of the tyro-
sine kinase Syk and phospholipase Cg2 on stimulation with
collagen were inhibited by ingestion of the high-quercetin
soup. This evidence supports previous in vitro and ex vivo evi-
dence presented by the authors (Hubbard et al. 2003, 2004)
and indicates that quercetin obtained in the diet is capable
of reducing GPVI signalling in platelets and therefore suppres-
sing platelet reactivity. The inhibitory effect of quercetin on
collagen-stimulated platelet activation via GPVI observed ex
vivo occurs therefore, at least in part, by the same mechanisms
as the in vitro addition of quercetin to platelets (Hubbard et al.
2003). The inhibition of PLCg2 tyrosine phosphorylation by
quercetin ingestion was less than that of Syk and was not
found to be statistically significant. PLCg2 tyrosine phos-
phorylation can occur via signalling pathways in addition to
that of GPVI, so interference from other pathways may have
masked detection of the inhibition of PLCg2 tyrosine phos-
phorylation. Collagen-stimulated Syk tyrosine phosphoryl-
ation was negatively correlated with the area under the
curve for the high-quercetin soup plasma profile. This corre-
lation suggests a major role for Syk tyrosine phosphorylation
in the inhibition of platelet function by quercetin ingestion.
In recent years, a number of dietary sources of inhibitors of
platelet function have been reported, although the relationship
between diet, platelet function and pathology remains unre-
solved. This area of research has been largely prompted by epi-
demiological data, suggesting that diet and CVDmay be linked.
The evidence presented here not only suggests that quercetin
may play an important role in health and disease regarding the
inhibition of platelet function and hence a possible decreased
risk of thrombosis, but also highlights the potential role of
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quercetin as an inhibitor of a number of cell-signalling mechan-
isms in vivo. The discovery that the effects of quercetin on cell-
signalling mechanisms ex vitro can be reproduced after inges-
tion of quercetin as a human dietary supplement (Hubbard
et al. 2004) and from a dietary source such as onion soup may
have repercussions for the role of quercetin in a number of dis-
ease states, including heart disease and cancer. The evidence
presented here also further substantiates the epidemiological
data suggesting that those who preferentially consume high
amounts of apples, onions, redwine and tea containing high con-
centrations of quercetin have a reduced risk of CVD (Hertog
et al. 1993, 1995; Hollman et al. 1996).
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